Comment on

• Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

  [No authors listed] [No authors listed] Neurology. 1995 Jul;45(7):1277-85. Neurology. 1995. PMID: 7617182 Clinical Trial.